|
Jan 10
|
Even after rising 12% this past week, Lifecore Biomedical (NASDAQ:LFCR) shareholders are still down 39% over the past five years
|
|
Nov 20
|
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
|
|
Nov 17
|
Lifecore Biomedical Avoids U.S. Prosecution Over Alleged Mexico Bribes
|
|
Jul 7
|
QGEN vs. LFCR: Which Stock Is the Better Value Option?
|